baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Lantheus Holdings Inc/ US5165441032 /

2024-04-25 10:00:00 PM	Chg. -0.0100	Volume	Bid11:35:48 PM	Ask11:35:48 PM	High	Low
65.2000USD	-0.02%	603,019 Turnover: 24.16 mill.	63.8800Bid Size: 100	66.3000Ask Size: 200	65.2700	63.7600

GlobeNewswire 04-18 Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m...

GlobeNewswire 03-28 Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial ...

GlobeNewswire 03-05 Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024

GlobeNewswire 03-05 Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility

GlobeNewswire 03-04 Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patien...

GlobeNewswire 02-28 Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer

GlobeNewswire 02-26 Lantheus to Present at the TD Cowen 44th Annual Health Care Conference

GlobeNewswire 02-22 Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire 02-13 Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Tr...

GlobeNewswire 02-08 Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February ...

GlobeNewswire 01-23 Lantheus Announces CEO Succession Plan

GlobeNewswire 01-11 Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dota...

GlobeNewswire 01-09 Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment,...

GlobeNewswire 01-09 Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective The...

GlobeNewswire 01-09 Lantheus Reports Preliminary Fiscal Year 2023 Revenue

GlobeNewswire 01-03 Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire 2023-12-18 Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastat...

GlobeNewswire 2023-11-08 Lantheus to Present at the Jefferies London Healthcare Conference

GlobeNewswire 2023-11-02 Lantheus Reports Third Quarter 2023 Financial Results

GlobeNewswire 2023-10-19 Lantheus to Host Third Quarter 2023 Earnings Conference Call and Webcast on November 2, 2023, at 8:0...

GlobeNewswire 2023-09-01 Lantheus Announces Top Rated Oral Presentation Featuring PYLARIFY AI™ at the 2023 European Associati...

GlobeNewswire 2023-08-31 Lantheus to Present at the Wells Fargo Healthcare Conference

GlobeNewswire 2022-03-29 Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development

GlobeNewswire 2022-03-08 Lantheus Holdings to Present at the Barclays Global Healthcare Conference

Lantheus Holdings Inc/ US5165441032 /

If you wish to receive reply to your feedback, please provide your email address.